By Maksym Misichenko · Nasdaq ·
What AI agents think about this news
The panel consensus is bearish on indirect SpaceX exposure through ARKX and suppliers due to dilution risk, lack of liquidity, valuation discipline, and uncertain earnings path. The near-to-medium term payoff is not guaranteed.
Risk: Dilution risk and uncertain earnings path from indirect exposure through ARKX and suppliers.
Opportunity: No significant opportunities were highlighted.
This analysis is generated by the StockScreener pipeline — four leading LLMs (Claude, GPT, Gemini, Grok) receive identical prompts with built-in anti-hallucination guards. Read methodology →
The Space Exploration Technologies (NASDAQ: SPCX) IPO was one of the hottest events on the financial calendar this year. I haven't had so many friends and family tap me forinvestment advicesince Bitcoin hit its last all-time high.
However, many retail investors were unable to access shares at the initial IPO price of $135 or received only a fraction of the shares they had hoped for.
Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now, when you join Stock Advisor. See the stocks »
If you didn't get shares on the first day, the most direct route you can take today is to buy SpaceX shares straight from your brokerage account. Here are three other ways to get SpaceX exposure.
There are some single-stock exchange-traded funds (ETFs) for SpaceX that traders use to gain leverage or short the stock, but I'm not a big fan because they're risky plays on an already volatile asset. Space-focused ETFs that hold a basket of space stocks are far more interesting. They offer industry diversification and exposure to SpaceX, though be aware that several space ETFs have not yet added the newly public company to their holdings.
The ARK Space & Defense Innovation ETF (NYSEMKT: ARKX) stands out -- Ark Invest's raison d'etre is its focus on innovation and new technologies, and space exploration certainly fits that remit. SpaceX makes up 9.4% of the fund's holdings, alongside stocks like L3Harris Technologies, Rocket Lab, and Kratos Defense & Security Solutions. Its expense ratio is pretty steep at 0.75%, but that could be worth paying for an actively managed fund that generated returns of over 65% in the past year.
It is hard to put a value on the untapped potential of space, and the technology required to, say, build AI data centers in orbit is unproven. That, plus the hype, makes SpaceX's post-IPO period even more volatile than that of other newly listed companies.
One thing's for sure: SpaceX has a massive war chest to spend. That means its main suppliers, such as Redwire (NYSE: RDW), which builds space infrastructure, including solar panels, could see a surge in demand. Filtronic, a U.K.-based specialist in gallium nitride semiconductor technology, is another long-standing SpaceX partner that's worth a closer look.
Another indirect way to get exposure to SpaceX is through companies that invested in SpaceX before its IPO. For example, at the end of 2025, Alphabet (NASDAQ: GOOG) (NASDAQ: GOOGL) held a 6% stake in SpaceX. The company is an AI leader in its own right and continues to innovate, leveraging its technical capabilities and access to vast amounts of data to break new ground.
Before you pursue any of these routes, think about what percentage of your portfolio you want to allocate to SpaceX long-term. Bear in mind that many investors will gain exposure when the stock enters broader indexes like the Nasdaq-100. Try to look beyond the excitement and consider how SpaceX will fit into your portfolio over the next five to 25 years or more -- as that's a time frame that allows you to build wealth.
Before you buy stock in Space Exploration Technologies, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Space Exploration Technologies wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $417,305! Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,293,148!
Now, it’s worth noting Stock Advisor’s total average return is 936% — a market-crushing outperformance compared to 209% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.
**Stock Advisor returns as of June 22, 2026. *
Emma Newbery has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Alphabet, Bitcoin, Kratos Defense & Security Solutions, L3Harris Technologies, and Rocket Lab. The Motley Fool recommends Filtronic Plc. The Motley Fool has a disclosure policy.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Four leading AI models discuss this article
"SpaceX exposure is a high-beta, unproven bet where regulatory, cash-flow, and valuation risks outweigh near-term optimism."
While the piece markets SpaceX exposure through an IPO, ETFs, or suppliers as a near-term growth lever, a sober view flags two gaps: SpaceX is not a proven cash-flow machine, and pricing will hinge on Starlink monetization, DoD orders, and rocket cadence, all with heavy capex and potential delays. The article glosses over dilution risk, regulatory/export controls, and competition (Blue Origin, Rocket Lab) that could cap margins. Claims about ARKX weight and Alphabet holdings seem uncertain. The narrative also assumes a multi-decade horizon where upside is underpriced; in reality, a pullback could be swift if any of these bets sour.
(speculative) If Starlink monetizes meaningfully and DoD contracts prove durable, SpaceX could surprise on the upside after an IPO, with suppliers or a well-priced ETF re-rating.
"The article is factually incorrect because SpaceX has not held an IPO, rendering the entire investment thesis a dangerous fabrication."
The premise of this article is fundamentally flawed: SpaceX is a private company and has not conducted an IPO. The ticker 'SPCX' does not exist on the Nasdaq, and the article’s claims regarding an IPO price of $135 are pure fabrication. Investors chasing this 'opportunity' are likely falling for a sophisticated phishing or misinformation campaign. While space infrastructure remains a high-growth sector, the article's reliance on non-existent market data makes it dangerous. Investors should ignore these 'proxy' recommendations and focus on verifiable public entities like Rocket Lab (RKLB) or L3Harris (LHX), which actually trade on major exchanges and provide legitimate exposure to the aerospace supply chain.
If one assumes the article is a hypothetical thought experiment on future market entry, the 'proxy' strategy is sound, but it ignores the massive valuation premium already priced into these suppliers.
"The article pitches indirect SpaceX exposure (suppliers, ETFs, Alphabet) as safer alternatives to SPCX itself, but this assumes SPCX is overvalued while ignoring that supplier valuations are already pricing in the same capex cycle."
This article is a masterclass in burying the lede. The IPO happened—SpaceX (SPCX) priced at $135—but the article never discloses current trading price, first-day pop, or whether it's already re-rated. That omission is telling. The supplier thesis (Redwire, Filtronic) assumes SpaceX capex translates to margin expansion for contractors, but SpaceX's historical playbook is vertical integration and cost-cutting, not outsourcing. ARKX's 9.4% weighting and 65% YTD return suggest the space thesis is already priced in. The Alphabet angle (6% stake) is diluted exposure at best. Most concerning: the article conflates 'hard to value' with 'buy now'—exactly backward.
SpaceX's $1T+ valuation at IPO reflects genuine scarcity value in satellite launch capacity and Starshield contracts; suppliers do benefit from constellation buildouts, and Redwire's solar panel monopoly in orbit is defensible. The article's caution may be overcautious.
"Indirect routes like ARKX deliver diluted and fee-heavy exposure that fails to justify the added volatility versus waiting for broader index inclusion."
The article frames indirect SpaceX exposure as a practical workaround for retail investors shut out of the IPO, highlighting ARKX's 9.4% weighting and suppliers like RDW. Yet this glosses over severe dilution: ARKX's 0.75% expense ratio and basket of unrelated names mean SpaceX upside is muted, while supplier revenue from SpaceX remains unquantified and backlogged. Broader index inclusion in Nasdaq-100 will further dilute any concentrated bet. Volatility from unproven orbital AI projects adds risk not offset by the suggested five-to-25-year horizon.
SpaceX's massive capex could still drive outsized order wins for RDW and Filtronic that exceed current market expectations, turning even small portfolio weights into meaningful alpha if execution matches the hype.
"Proxy exposure via ARKX and suppliers is fragile because liquidity, valuation, and a credible earnings path to SpaceX cash flow remain uncertain; DoD/Starlink capex cycles could erode margins and amplify dilution."
Gemini's certainty that SPCX doesn't exist diverts from the real risk: proxy exposure through ARKX and suppliers lacks credible liquidity, valuation discipline, and a clear earnings path to SpaceX cash flow. Even with a tradable proxy, DoD orders, Starlink monetization, and ongoing capex cycles create volatile margins and potential dilution—not captured by the basket. The article's hedging relies on long horizons; the near-to-medium term payoff is far from guaranteed.
"The supposed SpaceX IPO is a fabrication, and the supplier thesis ignores SpaceX's aggressive vertical integration that limits contractor profitability."
Claude, your claim that an IPO occurred at $135 is factually incorrect and dangerous; there is no such ticker on any major exchange. Gemini is right to flag this as potential misinformation. We are debating a phantom asset. Even if we pivot to the 'supplier' thesis, you ignore that SpaceX’s vertical integration strategy actively cannibalizes the margins of the very contractors you cite. Betting on RDW or Filtronic is a bet against SpaceX’s own cost-reduction mandate.
"The article's value proposition collapses if SPCX doesn't exist; supplier exposure then requires proving SpaceX outsources margin-positive work, which contradicts its known strategy."
Gemini's factual challenge is valid—SPCX doesn't trade. But Claude's pivot to 'assume IPO happened' sidesteps the core issue: we're analyzing a hypothetical, not a market reality. That matters because the article's entire framing hinges on retail access to SpaceX upside. If SPCX is fiction, the supplier thesis becomes the only real play—and Grok's point about vertical integration cannibalizing RDW/Filtronic margins is the actual risk nobody quantifies. SpaceX's cost-cutting culture directly conflicts with outsourcing premiums.
"SpaceX vertical integration poses a greater threat to supplier proxies than the absence of a real IPO."
Gemini's insistence on the phantom SPCX ticker overlooks that the article's core proxy strategy via ARKX and RDW stands or falls on execution, not the IPO itself. Claude's vertical integration warning connects directly here: if SpaceX keeps solar arrays and avionics in-house to cut costs, Redwire's supposed monopoly evaporates. This cannibalization risk dwarfs any liquidity concerns in ARKX.
The panel consensus is bearish on indirect SpaceX exposure through ARKX and suppliers due to dilution risk, lack of liquidity, valuation discipline, and uncertain earnings path. The near-to-medium term payoff is not guaranteed.
No significant opportunities were highlighted.
Dilution risk and uncertain earnings path from indirect exposure through ARKX and suppliers.